Circulatory Health magazine
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Circulatory</strong> <strong>Health</strong><br />
Magazine<br />
"I've never regretted<br />
opting for the biological<br />
heart valves"<br />
37 researchers, patients, students and<br />
healthcare professionals tell us<br />
how to improve cardiovascular care<br />
UMC Utrecht<br />
Center for for <strong>Circulatory</strong> <strong>Health</strong> <strong>Health</strong>
16<br />
12<br />
20 42<br />
28<br />
44<br />
14<br />
46<br />
22<br />
43<br />
26
Contents<br />
06 Promising research<br />
into lower blood pressure thanks to<br />
implant<br />
07 Outpatient report complicated<br />
hypertension<br />
10 Heart-on-a-chip<br />
12 The LVAD team:<br />
who plays which role?<br />
14 "I might even win another prize<br />
some day"<br />
16 Patients are partners<br />
in care, research and education<br />
18 Facts & Figures<br />
20 Wealth of data<br />
in Utrecht Cardiovascular Cohort<br />
22 All information on hand in the<br />
consulting room<br />
23 "Not just for myself, but for<br />
everyone"<br />
24 News<br />
26 I feel as if I'm carrying a time<br />
bomb inside me”<br />
30 Heart failure due to heart muscle<br />
stiffness<br />
32 Big Data @ Heart:<br />
Sharing data and discovering trends<br />
35 "Combining forces"<br />
36 Joyce Browne studies high blood<br />
pressure in pregnant women<br />
37 Global <strong>Health</strong>:<br />
Global insight into cardiovascular<br />
diseases<br />
38 The biological clock of the heart<br />
40 Multidisciplinary outpatient<br />
Center for <strong>Circulatory</strong> <strong>Health</strong><br />
42 "This daily check-up<br />
reassures me"<br />
43 A patch against a stroke?<br />
44 Aspirin:<br />
more than just a painkiller<br />
46 U-Prevent:<br />
smart website about customized<br />
medication<br />
49 Imaging of heart failure<br />
28 "Locking in on promising<br />
students"<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 3
4 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Our heart's desire is…<br />
...to give all our patients quality care, regardless of<br />
whether they have clogged arteries or heart failure<br />
...to develop methods that help<br />
our patients<br />
…to train doctors who have an eye for the<br />
patient as a whole instead of just the disease<br />
...to design methods that predict the<br />
individual risk of cardiovascular disease<br />
…to help patients change their lifestyle<br />
…to train people around the world who<br />
help patients with cardiovascular<br />
disease, also in developing countries<br />
…to conduct research that society<br />
really needs<br />
At the strategic theme <strong>Circulatory</strong> <strong>Health</strong><br />
of UMC Utrecht, we work hard every day<br />
to fulfill this heart's desire one step at a time.<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 5
Promising research into lower<br />
blood pressure thanks to implants<br />
Deeply touched, a patient came to<br />
consulting hour. Overjoyed. Because his<br />
sky-high blood pressure had returned to<br />
normal. And because he had found a job<br />
again. This patient had been treated with<br />
the Mobius implant, a therapy being<br />
studied by internist-vascular physician<br />
Wilko Spiering.<br />
If your blood pressure remains high despite medication,<br />
you may qualify for a Mobius implant. "And also if there is<br />
no underlying cause, such as an adrenal gland disorder or<br />
kidney failure," adds Wilko." A Mobius is a stent-like implant<br />
that is placed in the carotid artery. It boosts the signals<br />
from the baroreceptors, which lowers blood pressure,<br />
immediately after implantation. To date, we see an average<br />
and persistent lowering of the blood pressure of 24 points<br />
(systolic pressure) and 12 points (diastolic pressure), in<br />
addition to a need for less medication. I am hopeful about<br />
this new treatment. But hope is not enough, we must<br />
know for sure."<br />
High blood pressure<br />
increases the risk of<br />
cardiovascular disease. High risk<br />
(high blood pressure) is one of<br />
the research themes of the<br />
strategic theme <strong>Circulatory</strong><br />
<strong>Health</strong>. We pay special attention<br />
to patients with high blood<br />
pressure that is difficult to treat<br />
or related to pregnancy.<br />
With Wilko as leading scientist, an international study was<br />
launched last year that leaves nothing to arbitrariness or<br />
subjectivity. "The study is a double-blind one. This means<br />
that neither the researcher nor the patient knows whether<br />
the Mobius implant has actually been implanted. To this<br />
end, an entire 'set' has been organized in the angio room<br />
so that patients who do not receive the implant do<br />
experience it as a real implantation when they're on the<br />
operating table. They are given a line, they feel warmth in<br />
their neck, the real thing. After all, high blood pressure is<br />
not like a broken leg; emotions have a lot of impact. And<br />
what we're seeing so far is that the blood pressure of those<br />
who did get the implant decreased immediately, while that<br />
didn't happen in patients who didn't get it. I'm enthusiastic<br />
about this innovation, because I want to give my patients<br />
the best possible treatment. That's also why I temper<br />
myself: aren't I overly enthusiastic? Because you can only<br />
achieve the best results in healthcare based on methodical<br />
and objective research.”<br />
6 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Nicolasa follows a<br />
comprehensive screening<br />
program because of her<br />
blood pressure<br />
A 15-minute walk<br />
"Great that they can really help me here," says Nicolasa Alejandro. She<br />
has had high blood pressure for many years, with different examinations<br />
and constantly changing medication. But her blood pressure remained<br />
far too high. Now, Nicolasa is a patient at the outpatient clinic for<br />
complicated hypertension of the Center for <strong>Circulatory</strong> <strong>Health</strong>. ><br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 7
It is Tuesday morning, 7:45 a.m. Nicolasa enters through the revolving door of the UMC<br />
Utrecht, together with her daughter-in-law Sharine. She's fifteen minutes late. "Traffic<br />
jam", she explains, "everything was deadlocked" and despite her cane she hurries to the<br />
Internal Medicine outpatient department. Sometimes she grimaces with pain, because<br />
she has had a blood pressure monitor around her arm for 24 hours, which still continues<br />
to pump up tightly. "I hardly slept because of it. It's great that it comes off soon."<br />
"It started with a headache and pain in my<br />
neck every day," Nicolasa remembers. "High<br />
blood pressure, my family doctor told me. I<br />
received medication, but my blood pressure<br />
remained at 170/100. Far too high. And after<br />
my accident, it got much higher still. I took<br />
six different drugs. Eventually, I was referred<br />
to the outpatient clinic for complicated<br />
hypertension."<br />
As Nicolasa was eligible for the<br />
comprehensive screening program, she first<br />
had to cut back her medication, to ensure<br />
untainted research results. Nicolasa: "On<br />
April 10, I had my first major medical, which<br />
looked at risk factors. This was called SMART.<br />
My blood and urine were tested, my waist<br />
and hip circumference were measured, an<br />
abdominal ultrasound was done, and an<br />
ECG. Today is the second major examination.<br />
For this, I had to start a 24-hour blood<br />
pressure measurement yesterday, and I also<br />
collected my urine over these 24 hours."<br />
Upon arrival at the outpatient department,<br />
she is greeted by nurse Marieke Pol, who<br />
helps her to her bed.<br />
"This study looks at the possibility of a<br />
hormonal disorder in the adrenal glands,"<br />
Marieke explains to Nicolasa. "Or whether<br />
your adrenal glands produce too much of<br />
the hormone Aldosteron. This hormone<br />
regulates the salt and water metabolism in<br />
the body, and, as such, blood pressure. To<br />
measure this, you will be administered a total<br />
of two liters of saline solution through a drip.<br />
We will take blood samples and measure<br />
your blood pressure at specific intervals.<br />
Because Aldosteron is normally always<br />
produced when you move, we must take the<br />
measurements at rest. This means you will<br />
have to stay in bed for four hours."<br />
But first, Nicolasa has to take a 15-minute<br />
walk. "Immediately afterward, we will take a<br />
blood sample and measure your blood<br />
8 <strong>Circulatory</strong> <strong>Health</strong> Magazine
pressure after this light exercise," says Marieke.<br />
The 24-hour sphygmomanometer finally comes off,<br />
and a drip needle is inserted. Nicolasa walks to the<br />
outpatient laboratory, where she hands in her urine<br />
sample and continues to the vascular medicine<br />
outpatient clinic to hand in the sphygmomanometer.<br />
Plus the log that she filled in yesterday, so that all<br />
blood pressures can be linked to her activity level.<br />
Back in the outpatient department, Nicolasa sits<br />
down on the edge of the bed. First, the blood<br />
pressure in her right arm is measured: 181/107.<br />
Marieke asks Nicolasa whether she recognizes this<br />
result. "Yes, that's normal," she whispers. Measuring<br />
the other arm hurts. And the cuff keeps pumping<br />
up. "That means the blood pressure is very high<br />
and it is automatically measured again," explains<br />
Marieke. She's right, the blood pressure peaks at<br />
228/138. Marieke wants to take a blood sample<br />
through an IV needle, but that does not work. "We<br />
will take a separate sample." This, too, is not easy.<br />
"This often happens," says Marieke, "the blood<br />
vessels of people with high blood pressure are<br />
tougher and more difficult to prick." But Marieke is<br />
skillful and it's soon over, leaving Nicolasa to heave<br />
a sigh of relief. After this first blood pressure<br />
measurement and blood sampling, the saline<br />
solution in Nicolasa's IV is administered. She lies<br />
down for the next four hours. After a few weeks, all<br />
outcomes will be discussed with her.<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 9
10 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Heart-on-a-chip<br />
Willem Suyker, department head of cardiothoracic surgery and<br />
chairman of the Heart & Lungs division.<br />
It is possible: repairing the heart while optimally<br />
respecting the body. Willem Suyker repairs heart valves<br />
using a robot, a minimally invasive technology that he<br />
was the first to use in the Netherlands. Regeneration is<br />
more difficult, but this research field is also evolving.<br />
The latest of the latest is the heart-on-a-chip.<br />
"I am especially interested in regenerative medicine<br />
and surgery. It would be great if we could activate the<br />
self-healing ability of the body, for instance, by having<br />
the heart muscle tissue that has died grow again.<br />
There are indications that this should be possible, but<br />
a lot of research is required to find out how exactly<br />
this can be done.<br />
Printed heart muscle cells<br />
The latest development in regenerative research is the<br />
organ-on-a-chip. I am, of course, mainly interested in<br />
the heart-on-a-chip. This is a chip, only a few<br />
millimeters square, on which a patient's heart muscle<br />
cells have been printed: a miniscule, three-dimensional<br />
piece of cardiac tissue. That allows you to conduct a lot<br />
of experiments, as the chips are relatively easy to make.<br />
A liquid in the chip ensures that the substances that we<br />
add reach the cultured tissue. What will happen if we<br />
release substances that occur naturally in the body and<br />
that are potentially self-healing onto the heart tissue?<br />
Ultimately, we want to find those substances that can<br />
repair a heart.<br />
Fewer animal experiments<br />
The heart-on-a-chip is a means to unravel the complex<br />
human regenerative processes. This is the basis on<br />
which we hope to be able to develop therapies. It<br />
would be ideal, for instance, if people with an LVAD<br />
would no longer need it because the regenerated or<br />
newly grown heart muscle cells sufficiently improve<br />
their cardiac function. But that's still in the future. For<br />
now, we're working hard on the required research.<br />
Another benefit is that for this research method fewer<br />
animal experiments are needed. This is not only more<br />
humane, but also faster and cheaper.”<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 11
The LVAD team:<br />
who plays which role?<br />
Cardiologist<br />
The cardiologist and the patient together discuss what the<br />
possibilities are in case of severe heart failure. If treatment with<br />
medication and lifestyle rules do not work, an LVAD may help to<br />
bridge the time until a heart transplant. The cardiologists<br />
performs a number of examinations to see whether the heart can<br />
be supported with a pump.<br />
Cardiothoracic surgeon<br />
The cardiothoracic surgeon performs the surgery to implant the<br />
LVAD. Following the operation, the patient stays in intensive care.<br />
Once the patient is stable and no longer requires artificial<br />
respiration, they are transferred to the nursing ward.<br />
Hospitalization in intensive care usually lasts one week, the stay in<br />
the nursing ward an average of four weeks.<br />
MCS* nurse practitioner or clinical nurse<br />
specialist or specialized nurse<br />
(MCS coordinator)<br />
The nurse plays a central role throughout the process, from<br />
implantation until removal of the LVAD. She discusses the new<br />
lifestyle rules for living with an LVAD with the patient. An example<br />
is that the nurse assists the patient and trains them in caring for<br />
the wound where the wire exits the body. The nurse constitutes a<br />
tight team with the LVAD engineer.<br />
Annette Klinkert has the hereditary<br />
heart muscle disease PLN.<br />
This genetic disorder causes a<br />
disease of the heart muscle that<br />
significantly affects the pump<br />
function of the heart muscle. She<br />
received an LVAD to bridge the<br />
period until a heart transplant.<br />
The LVAD team supported<br />
Annette in matters concerning<br />
implantation of the LVAD. Who<br />
participates in the LVAD team,<br />
what is their position and what<br />
role do they play?<br />
LVAD engineer<br />
(technical MCS coordinator)<br />
The LVAD engineer gives the patient five or six lessons to explain<br />
how the LVAD works. For instance, how long the batteries last<br />
during the stay in hospital. Family and friends are also trained to<br />
familiarize themselves with the equipment. The LVAD engineer<br />
visits the patient daily and analyzes the data produced by the LVAD.<br />
12 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Social worker<br />
The social worker visits the patient at least once. The social<br />
worker can help with questions such as "How do I handle feelings<br />
of fear, dependence and uncertainty?" "How will I be able to<br />
function properly again when I'm back home?" The patient and<br />
the social worker discuss these and other issues.<br />
Physical therapist<br />
Once the patient is awake in intensive care, the physical therapist<br />
visits every day. The physical therapist helps the patient build up<br />
muscle again. This starts with short exercises, such as finger<br />
movements and slow cycling in bed. A patient must be able to<br />
walk 200 meters, climb stairs and operate the LVAD equipment<br />
independently before they can go home.<br />
What is an LVAD?<br />
An LVAD is a pump placed in the body that connects<br />
the left ventricle and the aorta. The LVAD ensures that<br />
sufficient blood can flow through the body again. The<br />
pump is powered by electricity and is connected to a<br />
cable that exits through the abdominal wall. The cable<br />
is connected to a battery-powered controller (and on<br />
mains current during the night).<br />
UMC Utrecht implanted the first LVAD, a left<br />
ventricular assist device, in 1993. Every year,<br />
30 to 35 patients receive an LVAD. In the<br />
Netherlands, 200 people have an LVAD, and<br />
over half of them were treated in UMC Utrecht.<br />
Heart failure is one of the research themes of<br />
the strategic theme <strong>Circulatory</strong> <strong>Health</strong>.<br />
*MCS: Mechanical <strong>Circulatory</strong> Support is a collective term for<br />
long- or short-term support of blood circulation.<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 13
”I might even win another<br />
prize someday”<br />
Kiki's life revolves around<br />
horseback riding. When she<br />
suddenly fell ill, she didn't know<br />
whether she would ever win a<br />
competition again. Kiki (27): "Nine<br />
months ago, I had open-heart<br />
surgery to have a new type of<br />
biological heart valve implanted.<br />
Following surgery, I took<br />
anticoagulants for a while. When<br />
that stopped, I was back on my<br />
horse within two days. My doctor<br />
is very enthusiastic. During my<br />
most recent check-up, he told<br />
me: 'Just do your thing, I don't<br />
want to see you until next year'."<br />
14 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Flu?<br />
"Five years ago, I caught a bacterial infection. When I<br />
had a 40 degrees fever, I first thought I had the flu. But<br />
a month later my joints started to hurt. It appeared<br />
I had a streptococcal infection that had also<br />
affected my heart valves. We're living at a horse<br />
farm, with 45 horses. They need to be cared for and<br />
ridden full time. When I had ridden one horse, all I<br />
wanted to do was sleep on the couch. My body was<br />
worn out.<br />
New heart valves<br />
I had to have heart surgery. That was a real downer, I<br />
was only 26. In consultation with the thoracic<br />
surgeon, we opted for a new type of biological heart<br />
valve. That choice had to do with my desire to have<br />
children and above all with horse riding. With<br />
mechanical heart valves, you have to take<br />
anticoagulants your entire life. That makes horseback<br />
riding more awkward. With a biological valve, you are<br />
off anticoagulants quite soon. And they expect that<br />
this new type lasts longer. I knew I wanted to go for it.<br />
Everything for horseback riding<br />
I was so happy when I opened my eyes in IC. I'd<br />
made it, I could start building again. My studies to<br />
become an equine sports teacher had been delayed<br />
quite a bit. I started that again, going to school one<br />
day and doing an internship two days a week. After<br />
the surgery, I wanted to ride all the time, preferably<br />
six horses a day. But I adjusted that a bit. I listen to<br />
my body when it tells me I need rest. I keep one day<br />
a week free. It's good to know I have that freedom.<br />
No regrets<br />
I've never regretted opting for the new biological<br />
valves. I chose them because of my horse racing.<br />
And it worked out well. The doctor told me: 'You're<br />
so positive, it's infectious! It comes naturally.<br />
Surgery like that isn't nothing. But it wears off and<br />
becomes part of yourself. My life has gone back to<br />
normal. And that's great."<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 15
Patients are partners in care,<br />
research and education<br />
"Not just looking at the medical problem that a<br />
patient has, but at the entire cardiovascular<br />
system, the human being as a whole. That is the<br />
core of the Center for <strong>Circulatory</strong> <strong>Health</strong>. Every<br />
week, we treat an increasing number of patients in<br />
the Center for <strong>Circulatory</strong> <strong>Health</strong> and we learn a<br />
lot from that." Providing state-of-the-art care is<br />
one of the goals of the strategic theme <strong>Circulatory</strong><br />
<strong>Health</strong>. An interview with vicechairman of the<br />
UMC Utrecht Executive Board Frank Miedema and<br />
strategic theme chairman Rick Grobbee.<br />
Rick: "Just imagine the position of a patient who's had a stroke, who has to<br />
go to the vascular surgeon to have his carotid arteries checked, visit the<br />
cardiologist for a heart rhythm disorder, and 'pop by' the internist for<br />
diabetes. Before you know it, you're four months down the road until<br />
you've seen all these doctors. Here at the Center for <strong>Circulatory</strong> <strong>Health</strong>, we<br />
do things differently. What is more effective than having the neurologist,<br />
vascular surgeon and cardiologist be involved from the start? And having<br />
them consult intensively about these patients?” This is possible at the new<br />
Center of <strong>Circulatory</strong> <strong>Health</strong> of the strategic theme <strong>Circulatory</strong> <strong>Health</strong>,<br />
because all these specialists work at one and the same location.<br />
It was organized based on the patients' perspective. That focus not only<br />
applies to care, but also to research. Frank is clear about that. "Patients are<br />
increasingly becoming partners in our research. Their voice and that of their<br />
patient organizations are important for the choice of research we conduct.<br />
That really feels different. But this is a large public debate. Everyone is<br />
thinking about how we can get more from research, have a greater impact.<br />
The logical consequence is that doctors always have to ask themselves<br />
whether they really have the patients and their families on board.<br />
Knowing, captivating and holding on to new talents<br />
"Real changes and innovation in care require more than one specialty.<br />
That is where the strategic themes come in. "They bring more doctors of<br />
all sorts and conditions together, across departments, and teams<br />
consisting of a wide variety of researchers, such as epidemiologists,<br />
geneticists and imaging specialists. When they understand each other,<br />
you can generate real changes."<br />
There are more and more of these cross-disciplinary collaborations in<br />
the hospital. The Jacob Jongbloed Talent Society is a good example.<br />
This successful talent program for young post-graduates was named<br />
16 <strong>Circulatory</strong> <strong>Health</strong> Magazine
after the professor who developed the<br />
artificial heart at UMC Utrecht. Rick: "As<br />
strategic theme, we have granted a sum of<br />
money to the participants of this program<br />
to have them draw up a research proposal<br />
together. The common denominator is<br />
their talent. The participants work in<br />
different departments, from very basic to<br />
highly applied research.<br />
That inspires and helps them take further<br />
steps.” Rick emphasizes that he believes<br />
that each strategic theme must pay a great<br />
deal of attention to education and talent<br />
development. "You want to know, captivate<br />
and hold on to these new talents."<br />
“What is more<br />
effective than having<br />
the neurologist,<br />
vascular surgeon<br />
and cardiologist be<br />
involved from the<br />
start?”<br />
Human side<br />
The strategic theme is a key connector<br />
in- and outside the hospital to reach a<br />
common goal: improving human health<br />
and creating the healthcare of the future.<br />
Frank concludes by saying that the<br />
patients' perceptions are extremely<br />
important. "We'd lost sight of that a bit.<br />
But with societal impact as our objective,<br />
we have organized our strategic themes<br />
in such a way that they emphasize this<br />
human side. In care, research and<br />
education.”<br />
Frank Miedema and Rick Grobbee<br />
Our mission: to play a leading role globally in<br />
decreasing the burden of cardiovascular disease.<br />
Our vision for realizing this is:<br />
providing state-of-the-art and patient-centered care,<br />
research and education to prevent and treat<br />
cardiovascular diseases and to improve the quality of<br />
life of patients with such diseases.<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 17
Facts & Figures<br />
The heart<br />
There are some 1.4 million patients with cardiovascular<br />
disease in the Netherlands.<br />
Heart failure<br />
Heart failure means<br />
that the heart cannot<br />
effectively pump blood<br />
through the body. Every<br />
year, about 40,000<br />
people receive the<br />
diagnosis heart failure.<br />
53% of them are<br />
women, 47% are men.<br />
Stroke is a collective<br />
term for TIA, cerebral<br />
infarction and brain<br />
hemorrhage. Every year,<br />
some 41,000 people<br />
suffer from a stroke.<br />
That's about 113<br />
people every day.<br />
Weight<br />
Over half of the Dutch<br />
population is overweight.<br />
Over 10% of them are<br />
morbidly obese. A healthy<br />
weight reduces the risk of<br />
cardiovascular disease.<br />
Aneurysm<br />
About 300,000 people in the<br />
Netherlands have a brain<br />
aneurysm, a dilated artery in<br />
the brain.<br />
High risk: femalespecific<br />
factors<br />
1 in 4 women in the<br />
Netherlands dies from<br />
cardiovascular disease.<br />
Every day, 306 women are<br />
hospitalized because of a<br />
cardiovascular disease.<br />
In the Netherlands there<br />
are approximately<br />
670,000 women with a<br />
cardiovascular disease.<br />
In the Netherlands<br />
57 women die from<br />
cardiovascular disease<br />
every day. That is more than<br />
two women every hour.<br />
The heart is a<br />
pump that pumps<br />
around 4 to 5 liters<br />
of blood per<br />
minute. The blood<br />
contains oxygen<br />
and nutrients for<br />
all muscles and<br />
organs.<br />
Exercise reduces the risk<br />
of cardiovascular disease<br />
Exercise at least 2.5 hours<br />
a week with moderate<br />
intensity. For example, go<br />
cycling or walking a few<br />
days a week. Do activities<br />
that strengthen your<br />
muscles and bones at least<br />
twice a week.<br />
18 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Blood vessels<br />
An adult has 5 to 6 liters of<br />
blood in their body. The heart<br />
circulates this blood in a<br />
vascular system.<br />
Every year, 20 million<br />
people around the world<br />
die from cardiovascular<br />
disease. Between 1990 and<br />
2015, the mortality rate<br />
increased by about 50%.<br />
Blood vessels distribute the blood from the heart throughout the<br />
body. The total length of all these blood vessels is 100,000 kilometers.<br />
High risk: diabetes<br />
Over 830,000 people in the Netherlands know they have<br />
type-1 or -2 diabetes. It is estimated that another<br />
200,000 people have type-2 diabetes without being<br />
aware of it. Diabetes patients run a greater risk of<br />
cardiovascular disease, such as a heart attack, heart<br />
failure or a stroke. That risk is slightly greater in women<br />
than in men.<br />
High risk: blood pressure<br />
1 in 3 people in the Netherlands<br />
has high blood pressure; among<br />
the over-60s, this is 2 out of 3.<br />
High blood pressure increases<br />
the risk of cardiovascular diseases<br />
and kidney damage.<br />
Over 100 principal investigators are active in the<br />
strategic theme <strong>Circulatory</strong> <strong>Health</strong>, which has already<br />
resulted in over 9,000 publications, and about<br />
50 doctoral degrees every year.<br />
Approximately<br />
1 in<br />
6 patients<br />
in UMC Utrecht<br />
has a cardiovascular<br />
disease.<br />
1 in<br />
4 patients<br />
with cardiovascular<br />
disease receive care<br />
from more than one<br />
specialist (cardiologist,<br />
vascular surgeon,<br />
internist, vascular<br />
physician,<br />
neurologist).<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 19
20 <strong>Circulatory</strong> <strong>Health</strong> Magazine<br />
Baukje van Dinther and Katrien Groenhof
Wealth of data in<br />
Utrecht Cardiovascular Cohort<br />
In healthcare, we collect a lot of data that we do not or hardly use for scientific<br />
research. This changes with the Utrecht Cardiovascular Cohort (UCC). Baukje<br />
van Dinther (manager UCC) and Katrien Groenhof (PhD student UCC) tell us<br />
more about this.<br />
Baukje, what is the UCC?<br />
"The UCC is a collaboration of all of<br />
the departments at the UMC Utrecht<br />
that treat patients with a cardiovascular<br />
disease or a risk factor for it.<br />
We combine healthcare and scientific<br />
research. For the UCC, we collect the<br />
same data on all patients, regardless of<br />
specialty. We adhere to the current<br />
Dutch guidelines for cardiovascular risk<br />
management. Because of the UCC, we<br />
have a risk profile for cardiovascular<br />
disease for each patient, which can<br />
then be used for care. With the<br />
patient's consent, we collect extra<br />
blood for (future) scientific research.<br />
That enables us to monitor the patient<br />
over time. The UCC is about the<br />
improvement of cardiovascular care in<br />
the broadest sense of the word. It is<br />
supported by the divisions that<br />
participate in the strategic theme and<br />
by ZonMW."<br />
What does your work day look<br />
like, Baukje?<br />
"I facilitate the UCC at UMC Utrecht.<br />
Facilitating this centrally, enables<br />
uniform registration of the collected<br />
healthcare data and the informed<br />
consent. To that end, I talk to a lot of<br />
people every day.” Katrien: "From<br />
secretaries to professors, you connect<br />
them all."<br />
Preventing and treating<br />
cardiovascular diseases can<br />
be further improved if we use<br />
medical data and<br />
measurements from patient<br />
care in our scientific research.<br />
That is why UMC Utrecht set<br />
up the Utrecht Cardiovascular<br />
Cohort (UCC), a collaboration<br />
of all departments and<br />
divisions in the strategic<br />
theme <strong>Circulatory</strong> <strong>Health</strong>.<br />
What answers will the UCC be<br />
able to provide?<br />
"<strong>Health</strong>care professionals ask patients<br />
for broad-ranging informed consent,<br />
suitable for a wide range of research<br />
questions. These questions are taken<br />
from practice, such as the questions<br />
Katrien is working on. It is good that<br />
you came, Katrien, it really gives the<br />
UCC a boost. As Katrien uses the data<br />
and assesses the quality, it is also<br />
possible to make improvements at an<br />
organizational level. The data of the<br />
UCC are from and for all specialties.<br />
Everyone with a question to be<br />
answered can use them. So if you have<br />
a research question: let us know!"<br />
(www.umcutrecht.nl/UCC)<br />
Katrien, how long have you been<br />
working for us?<br />
"I was hired a year ago as a PhD<br />
student at the UCC. In short, my thesis<br />
is about improving care for<br />
cardiovascular patients. These patients<br />
see various specialists: cardiologist,<br />
endocrinologist, geriatrician,<br />
gynecologist, nephrologist,<br />
neurologist, vascular surgeon and<br />
vascular internist. And at different<br />
times in their lives, from being a<br />
pregnant woman to an elderly patient.<br />
The UCC ensures that data on all these<br />
patients are collected in the same<br />
manner, which makes it easier to<br />
discover differences and similarities<br />
between them. Using the data<br />
collected in the UCC, I can see how<br />
effectively the LDL cholesterol ('bad<br />
cholesterol') of our patients is treated<br />
or how important family history is for<br />
predicting cardiovascular diseases."<br />
What is the aim of your research?<br />
"Cardiovascular diseases do not end on<br />
the threshold of one specialty or even<br />
of the hospital. Cooperation is vital,<br />
both in daily care and in scientific<br />
research for the future. This project<br />
facilitates that. That's why I think the<br />
UCC is great!"<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 21
The Utrecht<br />
Cardiovascular<br />
Cohort (UCC) was<br />
set up in 2015 and<br />
is a growth model<br />
Since the start:<br />
Candidates invited:<br />
4400<br />
All information<br />
on hand in the<br />
consulting room<br />
Number of people<br />
seen: 3100<br />
Informed consent:<br />
1700<br />
No informed consent:<br />
1400<br />
"The risk of getting a cardiovascular disease within ten years, is x percent. And with this<br />
medication and quitting smoking, your risk will decrease significantly." This is how the<br />
conversation between the patient and doctor may go in the consulting room, with<br />
both looking at a dashboard together. The dashboard illustrates how treatment and a<br />
change in lifestyle could benefit the patient's health.<br />
EDEN is the name of the application created under the<br />
supervision of cardiologist Folkert Asselbergs. The<br />
application presents a single overview of all of the patient's<br />
risk factors, linked to a personal risk score of getting a<br />
cardiovascular disease within the next ten years.<br />
"Getting at the best treatment and lifestyle together with<br />
the patients - that's my aim," says Folkert. "To that end<br />
digital support can be useful. Little exercise, age, smoking<br />
and high blood pressure are examples of risk factors.”<br />
There are numerous guidelines for all risk factors. Moreover,<br />
there are different studies and new insights for each<br />
guideline. Doctors know this, but do not immediately have<br />
all data on hand in the consulting room. This application –<br />
currently in HiX (electronic health record) – contains all the<br />
up-to-date guidelines linked to the situation of each<br />
individual patient, their weight, age, cholesterol values, etc.<br />
EDEN shows patients at a glance, in a single overview<br />
dashboard, what you're talking about, plus their personal<br />
risk score."<br />
22 <strong>Circulatory</strong> <strong>Health</strong> Magazine
"Not just for<br />
myself<br />
but for<br />
everyone"<br />
For the past year, Anja ter Avest (62) has<br />
received treatment at the UMC Utrecht<br />
for her high cholesterol level and an<br />
abnormal cardiogram. During that period,<br />
she participated in three scientific studies,<br />
including the Utrecht Cardiovascular<br />
Cohort (UCC). She does not mind doing<br />
this, as she has a medical-biological<br />
background through her studies and<br />
work. "I know it's important to have<br />
biological materials to achieve progress<br />
in science. Moreover, I'm very curious<br />
about how the body works and possible<br />
solutions that are found for medical<br />
problems. Not just for myself, but for<br />
everyone."<br />
"I don’t find it difficult to take part in<br />
research into the risk factors of<br />
cardiovascular diseases. I always look at<br />
the UMC Portal to see the results. I'm<br />
someone who wants to know things, and<br />
preferably a little more than the doctors<br />
want to tell me. When I see a UCC<br />
questionnaire online, I always fill it out<br />
immediately."<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 23
News reports<br />
Talented researchers<br />
receive scholarships<br />
Scientists Leo Timmers and Jesper Hjortnaes<br />
received a research grant, the Dekkerbeurs<br />
scholarship, from the Heart Foundation. All in all,<br />
13 talented scientists working for Dutch<br />
knowledge institutes received a personal research<br />
grant. The young researchers can use the money<br />
for conducting innovative research into<br />
cardiovascular disease.<br />
Maarten-Jan Cramer is<br />
Friend of the Year<br />
Stichting Vrienden UMC Utrecht has nominated five<br />
employees who have each in their own way<br />
committed themselves to a good cause within the<br />
hospital. According to staff members of UMC<br />
Utrecht, cardiologist Maarten-Jan Cramer deserves<br />
the title Friend of 2017. He has been getting on the<br />
tandem bicycle with patients for years in aid of heart<br />
failure research. An example for others.<br />
Congratulations!<br />
Quitting smoking after cardiovascular<br />
disease extends life by five years<br />
Two new<br />
expertise centers<br />
UMC Utrecht has two new<br />
expertise centers: the<br />
Center for Inherited<br />
Cardiovascular Disease and<br />
the National Expertise<br />
Center for Pseudoxanthoma<br />
elasticum (PXE). Patients can<br />
come to these certified<br />
expertise centers for rare<br />
disorders for diagnostics,<br />
treatment (if possible),<br />
cross-disciplinary care and<br />
assistance. Six to eight<br />
percent of the population in<br />
the Netherlands suffer from<br />
a rare disorder.<br />
Smokers with a cardiovascular disease who quit<br />
smoking on average live five years longer than<br />
non-quitters. And the chance of a next<br />
cardiovascular disease is postponed by an<br />
average of 10 years. This is the result of PhD<br />
research carried out by Johanneke van den<br />
Berg. She conducted a study among almost<br />
5,000 patients with cardiovascular disease, a<br />
third of whom continued smoking after a first<br />
heart attack, cerebral infarction or angioplasty.<br />
Test women who have had<br />
pre-eclampsia earlier for<br />
cardiovascular disease<br />
Women who have had pre-eclampsia<br />
should be tested earlier for cardiovascular<br />
disease. Current practice is that women are<br />
advised to go to their family doctor when<br />
they turn 50. But research by UMC Utrecht<br />
physician Gerbrand Zoet shows that these<br />
women have a greater risk of heart attack or<br />
stroke at a younger age.<br />
Over the past three years, he studied over<br />
160 women who have had pre-eclampsia.<br />
24 <strong>Circulatory</strong> <strong>Health</strong> Magazine
UMC Utrecht discovers treatment for PXE patients<br />
UMC Utrecht has discovered an effective treatment for a rare hereditary disease, PXE. Patients with this<br />
disease suffer from calcification of the skin, blood vessels and retina. This can cause skin lesions,<br />
vascular disorders and severe vision loss. Researchers at UMC Utrecht have now discovered that an<br />
existing medicine, etidronate, inhibits calcification.<br />
Collaboration with family doctors<br />
UMC Utrecht regularly consults family doctors about the<br />
organization and methods of the Center for <strong>Circulatory</strong> <strong>Health</strong>.<br />
Together, the specialists and family doctors determine who<br />
provides what type of care and discuss developments. This<br />
collaboration enables them to realize innovations and develop<br />
clever ideas to improve patient care: 'the right care in the right<br />
place'.<br />
Large-scale European study into<br />
the best dialysis therapy for kidney<br />
failure<br />
Headed by the UMC Utrecht, a study will<br />
be conducted over the next four years<br />
among 1800 kidney patients to find the<br />
best dialysis therapy. As part of its Horizon<br />
2020 program, the European Commission<br />
has awarded a grant of over 6.4 million<br />
euros to an international consortium<br />
headed by UMC physician Peter<br />
Blankestijn. The researchers intend to<br />
demonstrate that a relatively new dialysis<br />
method, hemodiafiltration, not only<br />
reduces the risk of getting the disease and<br />
dying from it, but also improves kidney<br />
patients' quality of life.<br />
Interactive<br />
e-module 'Life<br />
after a heart<br />
attack'<br />
In the Netherlands, 30,000 people are<br />
hospitalized because of a cardiovascular disease<br />
every year. Patients must then cope with lifestyle<br />
rules about nutrition, exercise and medication<br />
that reduce the risk of a second heart attack. This<br />
information has now been combined in the<br />
e-module 'Life after a heart attack' which patients<br />
can read at their leisure, either in the hospital or<br />
at home. UMC Utrecht and Stichting Vrienden<br />
UMC Utrecht created the e-module together with<br />
the Harteraad patient association.<br />
New man/woman differences found in detecting<br />
heart failure<br />
If you lump together research results for men and women, you<br />
miss relevant information to detect heart disease earlier. This is the<br />
result of PhD research by Aisha Gohar, conducted with support<br />
from the Hartstichting, the Dutch Heart Foundation. She<br />
discovered new difference between men and women with arterial<br />
calcification and heart failure. Moreover, she demonstrates that<br />
man/woman differences are often still ignored in cardiac research.<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 25
"I feel as if I'm carrying a<br />
time bomb inside me"<br />
Ellen Pauëlsen has dilated carotid arteries. Last week, a scan was done<br />
to see if the aneurysms had grown or shrunk. Professor in vascular<br />
surgery Gert Jan de Borst is a specialist.<br />
26 <strong>Circulatory</strong> <strong>Health</strong> Magazine
"How are you doing?," asks Gert Jan. Ellen Pauëlsen<br />
(64) from Hollandsche Rading is being treated by him<br />
for an aneurysm of the carotid arteries on both sides.<br />
Last year, the annual scan was done to check whether<br />
the aneurysms had grown or shrunk over the past year.<br />
"I'm fine," she answers. "I'm happy with the result of the<br />
scan; everything has remained stable. Yet I sometimes<br />
visualize how everything is looking on the inside. And I<br />
feel as if I'm carrying a time bomb inside me."<br />
An aneurysm, or<br />
bulge in an<br />
artery, is a common<br />
disorder. Aneurysm is<br />
one of the four<br />
research themes of<br />
the strategic theme<br />
<strong>Circulatory</strong> <strong>Health</strong>.<br />
We provide<br />
customized treatment<br />
and conduct research<br />
into aneurysms in the<br />
brain, carotid artery<br />
and aorta.<br />
Expertise Center<br />
UMC Utrecht became an expertise<br />
center in 2014. Research data on<br />
patients from all over the world are<br />
collected in a database. Gert Jan puts<br />
his patient's mind to rest: "A neck<br />
aneurysm usually does not grow and<br />
the chance that it ruptures is negligible.<br />
Unless a patient has a predisposition<br />
for connective tissue disorders. And<br />
you don't." Ellen wonders if it is<br />
possible that clots will form. "There is<br />
hardly ever any clot formation in<br />
aneurysms in the carotid arteries,"<br />
answers Gert Jan. "Moreover, your<br />
aneurysms are relatively small."<br />
Tinnitus<br />
The disorder is often discovered by<br />
accident. This was also the case with<br />
Ellen. She had tinnitus. The ENT<br />
physician did a scan to find out the<br />
cause. "Of course I was glad that I<br />
didn't have a tumor," she says. But the<br />
scan did expose the aneurysms." She<br />
wonders whether an aneurysm could<br />
cause the tinnitus. "It sometimes<br />
sounds like I can hear my blood flow to<br />
the rhythm of my heartbeat." Gert Jan<br />
tells her that this was studied once in<br />
another patient with tinnitus. In that<br />
case, the carotid artery was closed off<br />
for a short while using a small balloon.<br />
"The patient still heard the swishing<br />
sound," he explains. "So the aneurysm<br />
is not the cause."<br />
Distracted<br />
"How much does your tinnitus bother<br />
you?" asks Gert Jan. "It regularly<br />
hinders me in my activities," says Ellen.<br />
"And it can make me tired and grumpy."<br />
The ENT specialist has told her that a<br />
hearing aid might help. But that's a<br />
decision she prefers to postpone for<br />
now. According to Ellen there also is a<br />
psychological component. She<br />
recounts: "Yesterday, the sun was<br />
shining, and I went out to work in the<br />
garden. I'm a real outdoorsy type.<br />
When the birds are singing and the<br />
bees are buzzing, it doesn't bother me<br />
as much. Then I'm distracted in a<br />
pleasant way.”<br />
Stents<br />
Ellen finds it reassuring to have a scan<br />
every year. She wonders what will<br />
happen if the aneurysms grow. Gert<br />
Jan: "We can operate on the neck to<br />
remove the aneurysm or place a stent.<br />
We are conducting research to<br />
continually improve these stents. To<br />
this end, we make a three-dimensional<br />
image of the neck of an anonymized<br />
patient. We then print a life-like mold<br />
with which we experiment. Is the<br />
newly developed stent flexible and<br />
sturdy enough? Does it stay in place?<br />
Are any blood clots formed when it is<br />
placed?"<br />
Anticoagulants<br />
Ellen comes back to the danger of<br />
blood clots associated with aneurysms.<br />
"Wouldn't it be better to take<br />
anticoagulants, just to be safe?<br />
Because if a clot does form, it might be<br />
too late." Gert Jan explains that<br />
anticoagulants also have drawbacks.<br />
"They can cause a hemorrhage. And in<br />
your case, we don't want to take that<br />
risk." "I feel that I am in safe hands,"<br />
says Ellen. "But it's still a bit scary. At<br />
the same time, you learn to deal with<br />
it. I keep telling myself that there are<br />
worse things in life."<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 27
Sanne de Jong – University lecturer, Medical Physiology department<br />
Caroline Pham, first-year Master's student of Biology of Disease<br />
"Locking in on promising students"<br />
"I can conduct my own research!"<br />
Sanne de Jong teaches students of biomedical sciences and medicine<br />
with an interest in cardiovascular diseases. These regularly include<br />
people that UMC Utrecht is pleased to train and employ as<br />
cardiovascular researchers or physicians.<br />
How do you do this?<br />
"We not only teach basic knowledge of the cardiovascular system, we<br />
also link it to scientific research, right from the Bachelor's phase. We<br />
have, for instance, developed the elective programs 'Cardiac<br />
pathophysiology' and 'Vascular biology' for our Bachelor's students.<br />
Cardiovascular researchers contributing to these programs are all<br />
involved in current scientific strategic theme research. They give<br />
lectures and mentor students in writing their thesis. This way, we<br />
introduce students to everything that's going on in terms of<br />
cardiovascular medicine from an early stage. That can be very basic, at<br />
cell level, but also translational – such as animal model studies – or a<br />
clinical study with patients.<br />
In the Bachelor's phase, students mainly attend lectures. However,<br />
during their Master's research internship, they are really responsible for<br />
part of the research. This way, they learn in a practical setting how to<br />
conduct research and what it involves. This hands-on involvement in<br />
high-quality scientific research is extremely interesting for these<br />
students. But it's good for UMC Utrecht as well: this way, we can lock in<br />
on promising students early on. And that's important, because we'd love<br />
to welcome them as researchers or physicians. That's why we offer an<br />
attractive curriculum in UMC Utrecht, from the Bachelor's phase until<br />
the rest of their career. It's great to pass on my passion for the<br />
profession to the students. And it's great to see what excellent<br />
cardiovascular doctors and researchers UMC Utrecht trains and retains.”<br />
"As a Master's student, I have the freedom to<br />
develop into a researcher in the discipline of<br />
cardiovascular medicine. During my Bachelor's<br />
in Biomedical Sciences, I designed and set up a<br />
cardiac arrhythmia study. Now, during my<br />
Master's internship, I get the chance to actually<br />
perform this study. Which is great! My tutor is<br />
Marc Vos, Professor of Medical Physiology. His<br />
knowledge and experience in cardiovascular<br />
research has helped me become a good<br />
researcher. I am learning different research<br />
techniques, and there is a lot of attention to<br />
scientific thinking, writing and presenting.<br />
These are important skills for a researcher.<br />
And what's also great is that in cardiovascular<br />
education you are encouraged to do research<br />
abroad. A chance I won't miss for the world! In<br />
January 2019, I will go to Melbourne to continue<br />
developing my expertise in cardiac arrhythmia.<br />
What do I think of this form of education?<br />
Versatile, in depth, and aimed at current<br />
research. The lecturers are specialized in their<br />
disciplines and often involved in scientific<br />
research themselves. As a student, you are in<br />
direct contact with cardiovascular experts. This<br />
delivers high-quality education and helps you<br />
build a scientific network."<br />
28 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Elective programs<br />
for students<br />
Julius de Poel, third-year Bachelor's student of Biomedical Sciences<br />
"This basic knowledge means that I'm well prepared"<br />
"Last year, I took two elective programs about<br />
cardiovascular diseases. Both were so<br />
interesting that it made me realize that this is<br />
what I want to do. The lectures are given by<br />
enthusiastic speakers who know a lot about<br />
cardiovascular research, and the lecturers are<br />
always willing to talk to you.<br />
What's also great is that, as a student, you are<br />
free to choose the subject of your research<br />
proposal or essay, which means you can<br />
choose your preferred subject. In my case this<br />
is cardiomyopathy, which literally translates as<br />
'diseases of the heart muscle'. We know very<br />
little about the underlying biological<br />
mechanisms and genetics of these diseases. It's<br />
very interesting to think about what kind of<br />
research could improve diagnosis and<br />
treatment. I think the Bachelor's program<br />
prepares you well for your research internship<br />
during your Master's, which involves at least<br />
one internship cycle in a research group. This<br />
requires sound basic knowledge to help you<br />
understand what you're doing. And perhaps<br />
even contribute ideas. It would be great to find<br />
out after – or maybe even during– my Master's<br />
what the causes of cardiomyopathy could be."<br />
The strategic theme <strong>Circulatory</strong><br />
<strong>Health</strong> supports three elective<br />
programs for Medicine and<br />
Biomedical Sciences students.<br />
The program 'Cardiac diseases:<br />
from cause to treatment' is aimed<br />
specifically at the heart muscle<br />
and related disorders (heart<br />
failure, arrhythmia).<br />
The program 'The role of the<br />
vessel wall and blood flow'<br />
focuses on normal blood<br />
circulation and the effect of<br />
circulatory disorders. The<br />
program ‘Cardiac<br />
pathophysiology’ is aimed at the<br />
molecular basis, prevention,<br />
diagnosis and treatment of heart<br />
disorders.<br />
Talent development is a key theme in<br />
the strategic theme <strong>Circulatory</strong> <strong>Health</strong>.<br />
Every year, the strategic theme publishes an<br />
educational brochure for students of<br />
Medicine, SUMMA (Selective Utrecht<br />
Medical Master) and Biomedical Sciences.<br />
www.umcutrechthartenvaatcentrum-onderwijs.nl/<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 29
Heart failure<br />
due to heart<br />
muscle<br />
stiffness<br />
Cardiovascular disease researcher Hester den<br />
Ruijter studies heart failure in women. "I try to<br />
answer the question of why heart muscle<br />
stiffness affects women more than men."<br />
The signals in women<br />
"Heart failure as a result of a stiff heart muscle is a very<br />
serious disease," explains Hester. "People can hardly<br />
climb the stairs or ride a bicycle and are very short of<br />
breath. This form of heart failure, called diastolic heart<br />
failure, occurs more often in women than in men. At<br />
molecular level, we don't understand – yet – what's<br />
happening. We know far too little, which is why it is<br />
important to prevent the heart muscle from<br />
becoming stiff.<br />
Understanding the risks<br />
Hester wants to find out who runs an increased risk of<br />
heart muscle stiffness. "We have completed a thorough<br />
review of the literature. This showed that there<br />
isn't a single study on the early stages of heart failure<br />
that distinguishes between men and women. We're<br />
also analyzing the data on patients referred to a<br />
cardiology center by their family doctor. We review<br />
ultrasound images, we keep track of who is hospitalized<br />
for cardiovascular disease and who dies from it.<br />
Insight into the risks and the development pathways<br />
toward heart failure in men and women offers a solid<br />
basis for further research into the treatment of heart<br />
failure due to heart muscle stiffness."<br />
"Of course I am curious as a researcher," Hester<br />
concludes, "and I want to know exactly what's going<br />
on. But our research is urgent as well, in that the<br />
prognosis for this form of heart failure is very poor.<br />
There is no effective medication. Less than half the<br />
patients are still alive after five years. Our goal is to be<br />
able to really make a difference for these patients.<br />
1<br />
2<br />
3<br />
4<br />
5<br />
6<br />
7<br />
8<br />
9<br />
pain in the upper abdomen, jaw,<br />
back or neck<br />
shortness of breath<br />
extreme fatigue<br />
dizziness<br />
restlessness<br />
anxiety<br />
pain between the shoulder blades<br />
nausea<br />
vomiting<br />
There are different mechanisms at work in<br />
the cause of cardiovascular diseases in men and<br />
women. High risk (female-specific factors) is one of the<br />
research themes of the strategic theme <strong>Circulatory</strong><br />
<strong>Health</strong>. The research is aimed at discovering<br />
cardiovascular diseases in women earlier, treating it<br />
more effectively and, where possible, preventing it.<br />
30 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Four women talk about their heart<br />
"I survived breast cancer, but the chemo<br />
has caused heart failure. I was given an<br />
LVAD, and now I've fortunately gotten a<br />
donor heart.<br />
I hope that research can help prevent<br />
heart damage after chemo in the future."<br />
Hilda van der Veen<br />
"I got the same heart problems as my<br />
brother. It was discovered by means of<br />
a test for hereditary diseases that I have<br />
the hereditary heart muscle disease<br />
PLN. I understand that a test can be<br />
scary, but it can help prevent serious<br />
consequences like mine."<br />
Annette Klinkert<br />
"I encourage women in my environment to go see a<br />
doctor if they run an increased risk of heart<br />
problems. Go to the hospital, have a check-up, and<br />
don't let yourself be told off if age and symptoms do<br />
not exactly match."<br />
Loes van der Veen<br />
"I had high blood pressure for years, but no<br />
drug or treatment helped. The risk of heart<br />
failure kept increasing. I got a new implant in<br />
my carotid artery to lower my blood<br />
pressure. My blood pressure has decreased<br />
enormously, and it has given my life an<br />
enormous boost."<br />
Claire Labberté<br />
"Cardiovascular<br />
diseases are one of<br />
the main causes of<br />
death in women. It's<br />
vital that more<br />
research is done into<br />
the female heart.<br />
That's why I<br />
wholeheartedly<br />
support studies<br />
aimed at discovering<br />
cardiovascular<br />
diseases in women<br />
earlier, treating them<br />
better and, where<br />
possible, preventing<br />
them."<br />
Neelie Kroes<br />
Ambassador of research<br />
into the female heart<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 31
Big Data @ Heart:<br />
Sharing data and<br />
discovering trends<br />
The explosive growth in the quantity of<br />
digital data in our society is the new<br />
driver of innovation. This also applies to<br />
Big Data @ Heart. "We are living in a<br />
world full of fragmented data files, but<br />
once you share them, you pave the way<br />
for answering clinical questions within a<br />
short time frame."<br />
With his current research, cardiologist<br />
in training and clinical epidemiologist,<br />
Stefan Koudstaal seeks to unravel the<br />
patterns that exist in the years prior to<br />
discovering that patients suffer from<br />
cardiac failure. What are the type of<br />
complaints that prompt them to go see<br />
a doctor? Or what type of medication<br />
have they been prescribed? Stefan:<br />
"We hope to find the answers to these<br />
questions at Big Data @ Heart over the<br />
next few years."<br />
What are these big data exactly? Stefan:<br />
"To us, these are large quantities of data<br />
that are not stored in a standardized<br />
manner. They are basically very rough<br />
data on a lot of patients. They are not<br />
suitable for in-depth conclusions, but<br />
we can use them to look at certain<br />
patterns that help us identify diseases<br />
earlier and treat them better. At Big<br />
Data @ Heart, we study these patterns<br />
using data from Great Britain, Sweden,<br />
Spain and the Netherlands. Data from<br />
Sweden and Great Britain have already<br />
been compared as to the chances of<br />
survival after an acute myocardial<br />
infarction. These were corrected for<br />
how ill patients were when they were<br />
32 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Forty-kilometer tandem<br />
ride for research<br />
Stefan remarks that patients are increasingly involved in<br />
research, based on their concerns and questions, and in<br />
crowdfunding. "At special congresses for patients, we<br />
tell them in terminology they can understand what we<br />
have studied. It tells you whether your research<br />
question really addresses the patients' questions. An<br />
example of a study designed together with the patients<br />
is the study aimed at detecting heart failure earlier to be<br />
able to slow it down at an early stage.<br />
admitted to hospital, and showed that<br />
survival rates in Great Britain were far<br />
lower than in Sweden. The fact that this<br />
difference between two countries can<br />
be measured using big data shows that<br />
they are very suitable as a research<br />
method."<br />
Always the same number<br />
"How do we do this? We use electronic<br />
health records. These contain data that<br />
have been standardized for research of<br />
all patients who want to participate." He<br />
gives an example of health records kept<br />
by family doctors in Great Britain,<br />
><br />
Our UMC Utrecht tandem tour is the perfect time to<br />
discuss the study with patients while we are cycling.<br />
For this June tradition, doctors and patients ride a<br />
tandem together to raise money for heart failure<br />
research. This way, we combine attention to heart<br />
failure and attention to the importance of exercise.<br />
Participants in the tandem tour are the first to learn<br />
about the results of the study they designed together<br />
with Stefan's research group."<br />
Further information on Stefan's study:<br />
https://www.bigdata-heart.eu/<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 33
where they are a step ahead of the<br />
Netherlands: the diagnostic codes<br />
family doctors enter into the records<br />
can be used directly for research.<br />
"The British government regulates and<br />
subsidizes a lot of this. Every patient<br />
has an identifier, a number that is<br />
always used, for every research<br />
cohort."<br />
Although Stefan and his colleagues<br />
usually do not have highly accurate<br />
data, such as an ultrasound or certain<br />
blood test results, they do always have<br />
information on blood pressure and<br />
medicine use in the health records.<br />
"These are what we target within Big<br />
Data @ Heart. We are essentially a large<br />
international consortium in which<br />
several research groups cooperate.<br />
The ICT companies in the consortium<br />
enable us to compare the data.<br />
Together, we pave the way for<br />
answering the right clinical questions<br />
within a short time frame. It would<br />
make me very proud if we were to<br />
achieve this within the 5-year project<br />
term!"<br />
“We really have global data. Patient data from<br />
these family doctors and cardiologists are all in<br />
these research files."<br />
Rick Grobbee<br />
"When you look at multiple layers, you start to see<br />
the differences"<br />
Rick Grobbee, chairman of strategic theme <strong>Circulatory</strong><br />
<strong>Health</strong>: "We conduct a series of studies, such as Big Data<br />
@ Heart, to try to understand differences between<br />
patients better. We have a relatively effective but also<br />
somewhat simple idea of a patient with cardiovascular<br />
disease. For instance, we use six categories for which we<br />
have ten essential drugs. But when you take a closer look,<br />
there are differences: such as in reaction to therapy, in<br />
prognosis and whether we find a clear risk factor. While<br />
they all are patients suffering from cardiovascular<br />
disease, there is something different behind them all. We<br />
believe that the use of large databases such as Big Data @<br />
Heart will enable us to create a clear picture of smaller<br />
groups. It's the way forward, partly because of new data<br />
analysis technologies."<br />
"It is the strength of the 24 million data in Big Data @<br />
Heart and the diversity in this data that enable us to look<br />
at a patient from different angles. This gives us a<br />
360-degree picture based on the patient's genetic<br />
information, the interaction between genes and the<br />
environment, and the impact of metabolism and<br />
molecules. You only see the differences when you look at<br />
multiple layers."<br />
34 <strong>Circulatory</strong> <strong>Health</strong> Magazine
‘Combining forces’<br />
"The strategic theme's ambition is<br />
to be socially relevant for people<br />
with cardiovascular disease. We<br />
make an impact with new<br />
knowledge resulting from<br />
scientific research, specialized<br />
educational programs and a clear<br />
care profile. Together with<br />
healthcare professionals, we want<br />
to offer our care in a serviceoriented<br />
manner and with a high<br />
degree of patient satisfaction.<br />
To achieve this, collaboration with<br />
healthcare professionals in and<br />
outside the region is a key focus,"<br />
says Marco Houterman, program<br />
manager of the strategic theme<br />
<strong>Circulatory</strong> <strong>Health</strong>.<br />
The role of the program office is to develop policies for the<br />
strategic theme and facilitate research, care and education.<br />
"We work as a linking pin in the hospital. If we work<br />
together effectively, we can provide high-quality care, for<br />
instance for patients with multiple cardiovascular diseases.<br />
Researchers develop a research strategy together based on<br />
the four research themes: heart failure, aneurysm, stroke,<br />
and high risk. And students can learn about the discipline<br />
of cardiovascular medicine at an early stage.”<br />
Team<br />
"Our committed team works daily on this role. <strong>Health</strong>care<br />
adviser Wendy Gouw-Ellenbroek focuses on extending<br />
the cross-disciplinary outpatient Center for <strong>Circulatory</strong><br />
<strong>Health</strong>. Baukje van Dinther is manager of the Utrecht<br />
Cardiovascular Cohort. Marti Bierhuizen is coordinator of<br />
research/education and focuses on elective programs for<br />
students and supporting research groups of the research<br />
themes. Heleen Romeijn, Marketing & Communication<br />
adviser, is dedicated to positioning and presenting the<br />
Center for <strong>Circulatory</strong> <strong>Health</strong>. As program manager, I am<br />
responsible for projects of the program office and<br />
contribute to developing the strategy of our theme.<br />
Reducing cardiovascular disease<br />
"As a driver, facilitator and problem-solver, our team<br />
contributes in its own way to reducing the burden of<br />
cardiovascular disease. That's why we come to UMC<br />
Utrecht every day."<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 35
Joyce Browne studies high blood<br />
pressure in pregnant women<br />
Around the world, some 350,000 women die during childbirth, labor or the<br />
postpartum period every year. An important cause is high blood pressure during<br />
pregnancy. Research physician Joyce Browne wants to minimize this risk.<br />
High blood pressure in pregnancy can result in<br />
pre-eclampsia, which could put the health of mother<br />
and child at risk. Joyce conducts research among<br />
800 women who are between 26 and 34 weeks<br />
pregnant. She wants to find out whether it is possible<br />
to predict which women benefit from giving birth as<br />
soon as possible when they are ill, and for which<br />
women delivery can be postponed. Every day in the<br />
womb gives the child a better start in life.<br />
<strong>Health</strong> of mother and child<br />
She performs a second study among 400 women<br />
a year after childbirth. She studies how many of<br />
them still have high blood pressure, as well as the<br />
general health status of mother and child.<br />
She compares the results with those of 100 women<br />
who had a normal childbirth. Joyce conducts the<br />
first study in Ghana, the second in Nigeria. Not<br />
because no pregnant women die from the effects<br />
of high blood pressure in the Netherlands, but<br />
because this happens far less frequently than in<br />
the African countries: 7 out of 100,000 live births,<br />
compared to 340 in Ghana and 814 in Nigeria.<br />
Solid healthcare structure<br />
The second reason for choosing these countries is<br />
that they have a solid healthcare structure. Most<br />
women visit a midwife at least once. Moreover, the<br />
hospitals are fairly well organized, so that Joyce<br />
can carry out her research there and<br />
improvements in healthcare can be implemented.<br />
Joyce works together with local doctors and<br />
researchers. She's had to adapt to their different<br />
cultural backgrounds, but also finds this very<br />
instructive. "There is more of a hierarchy and<br />
people are not as direct. That has made me more<br />
careful. I no longer say: 'I suggest we do this or<br />
this'. That's become: 'Would it be an idea if we did<br />
this or this?'<br />
Joyce expects to present the results of both<br />
studies in 2020. She doesn't yet know what she will<br />
do afterward: "But it will be a job in which I can<br />
continue to make a meaningful contribution to<br />
improving the health situation of women. This<br />
currently matches perfectly with conducting<br />
research."<br />
36 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Senior university lecturer Kerstin Klipstein-Grobusch<br />
Global <strong>Health</strong>: global<br />
insight into<br />
cardiovascular diseases<br />
Contributions to global health for everyone. That's the mission of<br />
the researchers at Julius Global <strong>Health</strong>. How? By performing<br />
clinical epidemiological research.<br />
By coming up with innovative solutions in healthcare technology.<br />
And by training new generations of professionals in healthcare.<br />
These are the words of senior university lecturer Kerstin<br />
Klipstein-Grobusch. "Global <strong>Health</strong> looks for new solutions in<br />
the prevention and treatment of diseases, such as cardiovascular<br />
diseases.<br />
Cardiovascular health is a key theme of Julius Global <strong>Health</strong> research. Does<br />
the development of babies and children affect their cardiovascular health<br />
as adults?<br />
What do we learn when we compare diabetes and cardiovascular disease<br />
and their risk factors internationally? And can we find ways to prevent<br />
cardiovascular diseases and diabetes in high- and low-income groups?<br />
These are the three questions on which cardiovascular research at Global<br />
<strong>Health</strong> centers. The researchers always take the life-cycle perspective as a<br />
basis: the development from fetus, baby and child into adult.<br />
In the strategic<br />
theme <strong>Circulatory</strong><br />
<strong>Health</strong> heart and blood<br />
vessel health is a key<br />
theme. Our global target<br />
is research and education<br />
in the fields of diabetes<br />
and cardiovascular<br />
disease. Global <strong>Health</strong><br />
researchers cooperate<br />
with local and<br />
international partners.<br />
Kerstin explains that there are ongoing projects all over the world aimed at<br />
preventing cardiovascular diseases and diabetes. "Global <strong>Health</strong> researchers<br />
are involved in studies in Asia/Pacific and Africa, where they work together<br />
with local and international partners. In Oxford, Sydney and other cities,<br />
they conduct research into the effects of gender differences on common<br />
risk factors for cardiovascular disease. Or into the relationship between<br />
ethnicity and the prevention of cardiovascular diseases. In the RODAM<br />
study of obesity and diabetes among African immigrants, researchers<br />
compare Ghanaians with their compatriots in Amsterdam, London and<br />
Berlin. This way, they find out more about the complex interaction between<br />
environment and genetics that plays a role in the development of type-II<br />
diabetes and obesity. Research projects in Asia are aimed at improving the<br />
quality of stroke care in an environment that is lacking resources. And a<br />
study in South-Africa targets changes in the risk of high blood pressure in<br />
the long term in rural and urban population groups."<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 37
The biological<br />
clock of<br />
the heart<br />
38 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Did you know that the cells in our body have a 24-hour<br />
rhythm? And that this internal clock influences such functions<br />
as the regenerative ability of cells? Cardiologist Linda van<br />
Laake studies this fact and all of its implications. "There are<br />
indications that cardiac cells can handle a lack of oxygen<br />
better in the afternoon than in the early morning."<br />
Not only people, but also animals, plants and<br />
individual cells in our body - even when they<br />
are isolated on a Petri dish - appear to live by<br />
this 24-hour rhythm. A greater understanding<br />
of that rhythm could have a major impact for<br />
the medical world.<br />
Linda: "Heart cells appear to have a fixed<br />
circadian rhythm. Simply speaking, you could<br />
say that they are active during the day and<br />
rest in the evening. This could mean that the<br />
regenerative ability of cells, for instance after<br />
surgery, could also vary depending on time."<br />
Internal clock<br />
There is a lot we don't know yet about this<br />
'internal clock', but researchers suspect that<br />
the body prefers to perform certain tasks, such<br />
as repairing cells, at times that it does not have<br />
to be on stand-by for sudden action, such as<br />
running to catch a train. In some diseases, this<br />
circadian rhythm becomes unbalanced. This<br />
appears to be the case with heart failure, which<br />
decreases the pump function of the heart, after<br />
Heart failure is a<br />
chronic disease,<br />
gradually decreasing<br />
the pump function of<br />
the heart. Heart failure<br />
is one of the four<br />
research themes of the<br />
strategic theme<br />
<strong>Circulatory</strong> <strong>Health</strong>. By<br />
doing research, we<br />
want to improve the<br />
detection, prognosis<br />
and treatment of heart<br />
failure.<br />
a heart attack for example.<br />
Linda: "We currently study whether heart failure<br />
can be treated more effectively if you take the<br />
phase of the heart cells into account. This also<br />
provides an opportunity to solve a different<br />
problem: "The 24-hour rhythm and the resulting<br />
differences in cellular activity may explain why<br />
heart failure cannot be cured yet with stem cells."<br />
Stem cells are our body's primitive cells: they<br />
can still develop into all kinds of cells, such<br />
as blood, skin or heart cells. Scientists have<br />
been trying for years to repair the piece of<br />
heart muscle that has died after a heart attack<br />
using these stem cells. But that appears to be<br />
more difficult than we thought. "My focus is on<br />
improving the heart muscle cells cultured from<br />
stem cells using the 24-hour rhythm. In other<br />
words: transplanting the cells when they are<br />
in their 'optimal phase' in terms of therapeutic<br />
properties. Or manipulating them to make this<br />
optimal phase continuous."<br />
Early days<br />
While it is still early days for this research, the<br />
results so far are promising. Linda emphasizes:<br />
“It is important to realize that there are circadian<br />
rhythms. If we can work them out and adjust<br />
medical treatment to them, we stand to gain an<br />
advantage."<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 39
Pieter Doevendans<br />
> Linda van Tellingen<br />
Cross-disciplinary outpatient<br />
Center for <strong>Circulatory</strong> <strong>Health</strong><br />
> Esther de Haan<br />
> Suzanne Elstgeest-Grootenboer<br />
40 <strong>Circulatory</strong> <strong>Health</strong> Magazine
"This is the<br />
healthcare of<br />
the future”<br />
Nurse practitioner:<br />
for the best care as<br />
well as service<br />
“My colleagues and<br />
I are the linking pin<br />
in patient logistics"<br />
Pieter Doevendans Linda van Tellingen & Esther de Haan Suzanne Elstgeest-Grootenboer<br />
"We're here for the patients," says<br />
Pieter Doevendans, Professor of<br />
cardiology and responsible for<br />
care within the strategic theme.<br />
"In addition to providing the best<br />
possible care, it's the experiences<br />
of our patients that counts. They<br />
must be seen by different<br />
specialties and disciplines within<br />
a few hours and have to feel<br />
comfortable with that.<br />
A pleasant patient experience and<br />
improving the quality of care,<br />
these are the main goals of the<br />
cardiovascular outpatient clinic,<br />
says Pieter. "We work with<br />
different specialists, such as<br />
internal medicine, vascular<br />
surgery, neurology and cardiology.<br />
It is essential that we use uniform<br />
guidelines, which can differ<br />
significantly for the individual<br />
specialties. But with the outpatient<br />
clinic that's a thing of the past,<br />
which also benefits science.<br />
Providing this much care within<br />
such a short period of time hinges<br />
on the logistics. Logistics must be<br />
perfect, so that we can effectively<br />
collect all data and draw up a<br />
treatment proposal together. In<br />
addition, patients must be<br />
included more in science, for<br />
instance so that their DNA can be<br />
used for other genetic<br />
cardiovascular research. The times<br />
that a patient would go from<br />
consulting room to consulting<br />
room and specialists would<br />
determine what happens, are over.<br />
In the multidisciplinary outpatient<br />
clinic, focus is on the patient: this<br />
is the healthcare of the future.”<br />
Even though patients in the<br />
outpatient Center for <strong>Circulatory</strong><br />
<strong>Health</strong> see several healthcare<br />
professionals, they always have a<br />
nurse practitioner as permanent<br />
contact. "We know everything<br />
about every individual patient,"<br />
says Linda van Tellingen.<br />
"They come to us first with their<br />
questions about care and<br />
treatment."<br />
"We conduct the necessary<br />
preliminary work before a patient<br />
visits the specialist," explains Linda.<br />
"I update the medical history." Has<br />
the patient been hospitalized<br />
before, and for what? I review lab<br />
results and identify risk factors. Is<br />
the patient overweight, do they<br />
have a high blood pressure, do<br />
they smoke? To sum up, we focus<br />
on risk management. Because all<br />
patients who enter these doors<br />
have one thing in common: they<br />
are either already suffering from or<br />
run a high risk of cardiovascular<br />
disease. In addition to curative<br />
treatment, we also pay a lot of<br />
attention to prevention."<br />
Nurse practitioners also monitor<br />
cross-disciplinary cooperation.<br />
Linda: "When I notice during triage<br />
that we need a cardiologist in<br />
addition to the vascular surgeon,<br />
I see to it that the cardiologist is<br />
available the same morning. It's<br />
key that patients here receive the<br />
best care as well as service."<br />
From aneurysms and heart failure<br />
to vascular claudication: the<br />
outpatient Center for <strong>Circulatory</strong><br />
<strong>Health</strong> sees different patient<br />
groups for a combination of<br />
specialties. The team of medical<br />
assistants ensures that patient<br />
logistics run like a well-oiled<br />
machine. "Patients must be able<br />
to have all necessary<br />
examinations and interviews<br />
within half a day, like an express<br />
train," says medical assistant<br />
Suzanne Elstgeest-Grootenbroer.<br />
"The process starts with<br />
registration of the patient by the<br />
family doctor," Suzanne explains.<br />
"Or by a specialist in our or an<br />
external hospital.<br />
The referral is assessed by the<br />
attending physician. They<br />
determine which examinations and<br />
appointments with other<br />
specialties are necessary. My<br />
colleagues and I are the linking pin<br />
in the process of a patient's visit to<br />
the clinic. Teamwork is vital for<br />
this. We receive the patient and<br />
answer any questions they may<br />
have. But we also measure blood<br />
pressure, if necessary, and the<br />
pressure in the ankle and arm, the<br />
so-called ankle-brachial index, in<br />
preparation for the consultation<br />
with the doctor. We also arrange<br />
everything concerning wound<br />
care, from A to Z. And after the<br />
consultation, we conclude the visit<br />
to the clinic and schedule a<br />
follow-up appointment. All in all,<br />
the medical assistants are involved<br />
in the entire outpatient process.”<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 41
“This daily<br />
check-up<br />
reassures me”<br />
Every morning, patient Alfred Hagedoorn places<br />
his upper body on a special pad that connects to<br />
the sensor implanted in his pulmonary artery. That<br />
sensor measures the pressure and the results are<br />
sent directly online to his cardiologist at UMC<br />
Utrecht. "It feels safe to be checked at home every<br />
day and receive feedback from the hospital. It<br />
reassures me."<br />
In the spring of last year, Alfred had been short of<br />
breath for a while. He also suffered from dizziness.<br />
"I used to swim intensively every week. Until it went<br />
wrong in September: I thought I was choking. I had<br />
cardiac asthma, which means that leaking heart<br />
valves had weakened the left part of my heart to the<br />
extent that it could not process fluid sufficiently. This<br />
caused my lungs to fill up. I was hurried to UMC<br />
Utrecht by ambulance. After a few very scary<br />
breathless episodes, mitraclips were implanted<br />
through a groin catheter. These reduce the leaking<br />
of the heart valves. My health improved, but it wasn't<br />
optimal yet. In December, things went wrong again.<br />
I had cardiac asthma again and was rushed to UMC<br />
Utrecht. It turned out that because of the leaks in<br />
the heart valve, the two halves of my heart were no<br />
longer working synchronously. To remedy this, it<br />
was decided to implant a CRT-D pacemaker to<br />
synchronize the two ventricles. I really feel a lot<br />
better now."<br />
Computer in a pad<br />
Alfred also had a CardioMEMS HF system implanted,<br />
a miniature sensor in the pulmonary artery that<br />
directly measures pressure. When heart failure<br />
worsens, pressure in the pulmonary artery increases.<br />
Alfred: "I have a trolley at home, with a computer in<br />
a pad. I lie down on this every day; a voice tells me<br />
whether I'm positioned correctly. Information about<br />
the pressure in my pulmonary artery is sent through<br />
the implanted miniature sensor to the cardiologist.<br />
This means I don't have to go to hospital as often,<br />
while at the same time my doctor can react quickly<br />
if necessary. I'm only called when adjustment is<br />
necessary. I've had the system for two months now,<br />
and I'm called about once every two weeks, when<br />
the pressure appears to be too high and my<br />
medication is adjusted. This immediately prevents<br />
my heart failure from getting worse. With the attacks<br />
that I've had, this daily check-up is reassuring, for me<br />
and my family."<br />
42 <strong>Circulatory</strong> <strong>Health</strong> Magazine
A patch against a<br />
stroke?<br />
Every year, some 41,000 people in The<br />
Netherlands have a stroke. This can be a<br />
cerebral infarction or a brain<br />
hemorrhage. A cerebral infarction is<br />
caused by a clot that closes off a blood<br />
vessel; a hemorrhage is caused by a<br />
bursting blood vessel. Neurologist Bart<br />
van der Worp: "Fortunately, new<br />
treatments have greatly improved the<br />
prognosis for a brain infarction in recent<br />
years. Injecting an anticoagulant within<br />
4.5 hours can prevent a lot of brain<br />
damage. In addition, the clot can<br />
sometimes be removed through a<br />
catheter in the groin. The earlier you<br />
intervene, the better the prognosis."<br />
Stroke is a collective term for TIA,<br />
cerebral infarction and brain hemorrhage.<br />
Stroke is one of the four research themes of<br />
the strategic theme <strong>Circulatory</strong> <strong>Health</strong>. We<br />
study how we can improve treatment<br />
methods to reduce or eliminate the<br />
consequences of a stroke.<br />
Patch<br />
Unfortunately, only a small percentage of patients reach the<br />
hospital in time to get the anticoagulant, and the clot can<br />
only be removed in 10% of patients. "We are looking for<br />
complementary treatment," says Bart. One of the options is a<br />
nitroglycerin patch applied by ambulance staff.<br />
We started a trial in April: MR ASAP.<br />
Nitroglycerin has a vasodilating effect. Bart hopes that this<br />
means that patients with a cerebral infarction reach the<br />
hospital in a better condition. It also lowers the blood<br />
pressure, which may help in the event of a brain hemorrhage.<br />
Cheap and safe<br />
One medication for two different causes of a stroke - that<br />
almost sounds too good to be true. Bart thinks so too. "Two<br />
small-scale British studies have shown that the results appear<br />
to be favorable," he says. "We hope to be able to confirm this<br />
with this larger study."<br />
Nitroglycerin has been used as a medicine for over 100 years.<br />
It opens the coronary arteries in case of an imminent heart<br />
attack. Van der Worp: "It's also used in mining, to blast rock.<br />
But that requires several kilos, compared to only milligrams<br />
used in our research. In the clinic, nitroglycerin is cheap and<br />
safe. The damage following a stroke is usually very debilitating.<br />
We hope the patch limits the damage."<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 43
Neurologist in training Annemijn Algra<br />
Aspirin: more than just a painkiller<br />
Patients with a cerebral infarction or a precursor<br />
of this disease should immediately take aspirin,<br />
says clinical epidemiologist Ale Algra. He has been<br />
researching this drug throughout his career.<br />
And his interest has passed to his daughter<br />
Annemijn.<br />
One of the ingredients in aspirin is salicin, a substance<br />
originally produced from willow. It has an antifebrile<br />
and analgesic effect. The Greek doctor Hippocrates<br />
(approx. 400 BCE) already prescribed potions made<br />
from willow bark to counter pain. It had a bitter taste<br />
and patients would get stomach aches. In 1897,<br />
synthetic salicin was produced for the first time and<br />
made into the medication 'aspirin'. "A weird and<br />
wonderful medicine," says Ale. "It does not only work<br />
as a painkiller, it is also a platelet aggregation inhibitor,<br />
preventing platelets from sticking together to form<br />
clots that enter the bloodstream."<br />
Blood clot<br />
A blood clot may be caused by diseases such as<br />
atherosclerosis, or hardening of the arteries. The body<br />
sends platelets to the damaged vessel wall to repair it.<br />
These platelets clot together. "Sometimes a piece of a<br />
clot breaks away," explains Ale. "If this occurs in the<br />
carotid artery, it travels to the blood vessels of the<br />
brain. The longer the blood flow is interrupted, the<br />
greater the risk of severe brain damage."A small clot<br />
causes a TIA, a transient ischemic attack, with<br />
temporary symptoms of weakness and numbness.<br />
"A TIA is often a warning of a much more serious<br />
infarction," says Ale. "The likelihood of a recurrence is<br />
greatest during the first days after a TIA or cerebral<br />
infarction."<br />
Not tomorrow, but today<br />
Patients who run an increased risk of clots are<br />
prescribed aspirin for life. But Ale discovered that<br />
taking aspirin is most effective immediately after a TIA<br />
or cerebral infarction. In low doses: preferably 75 mg.<br />
Together with his colleague from Oxford, Prof.<br />
Rothwell, he recently published his findings in the<br />
medical journal The Lancet. Ale: "The earlier you take<br />
aspirin, the greater the chance of preventing another<br />
infarction. Do not wait for the doctor. No. Take aspirin<br />
44 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Clinical epidemiologist Ale Algra<br />
immediately." This recommendation was included in<br />
the protocol for strokes last year. Incidentally, this<br />
advice has been in place for much longer for people<br />
who had a heart attack. Ale: "We always have a box of<br />
aspirin in the kitchen cupboard."<br />
Drawbacks<br />
But aspirin also has its drawbacks. As the medication<br />
makes platelets less 'sticky', there is a greater risk of<br />
internal bleeding, particularly in the stomach and<br />
intestines. So everyone who takes the medicine daily<br />
and has an increased risk of bleeding is also<br />
prescribed a stomach protector. Moreover, the<br />
symptoms of a cerebral infarction – such as face<br />
drooping, trouble speaking, paralysis of the arm –<br />
may also be the result of a brain hemorrhage; only a<br />
scan can provide certainty in the event of 'a stroke'.<br />
Aspirin is counterproductive for a brain hemorrhage.<br />
Ale: "The risk of a hemorrhage is much smaller than<br />
that of an infarction. Moreover, a single aspirin does<br />
not do a lot of harm in case of a brain hemorrhage."<br />
Cancer prevention<br />
The passion for aspirin has passed from father to<br />
daughter: Annemijn Algra is neurologist in training<br />
and performed a literature review into the effects of<br />
aspirin. Annemijn: "Research with Professor Rothwell<br />
shows that people who take aspirin develop fewer<br />
tumors and that mortality among them is lower. I also<br />
found evidence for this in the literature. Aspirin<br />
reduces the risk of all types of cancer by almost 20%;<br />
for intestinal cancer this is almost 50%. It is still too<br />
early for a theory to explain this, but a possible<br />
mechanism could be that aspirin prevents metastases.<br />
Some guidelines recommend that people in their 50s<br />
take a low dose of aspirin every day by way of<br />
preventive medication.”<br />
Two-by-two<br />
A father and daughter who both work at the UMC<br />
Utrecht and who both have an above-average interest<br />
in aspirin sometimes causes confusion at home.<br />
Annemijn: "I get emails addressed to 'Dear colleague<br />
Algra', or my dad is asked to give consultations."<br />
Annemijn inherited the love for science from her<br />
father. "He used to have all kinds of gauges, to<br />
measure rainfall in his garden for instance. And when<br />
we hiked through the mountains he calculated how<br />
much altitude we had gained per minute. Ale gave me<br />
his two favorite mottos: Keep it Stupidly Simple and<br />
Think two-by-two. You can reduce all your questions<br />
to a single table."<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 45
A healthy lifestyle is usually the best way of living to<br />
a ripe old age in one piece. Some people must take<br />
medication to prevent cardiovascular diseases in<br />
addition to living a healthy lifestyle. But for whom<br />
are they useful?<br />
46 <strong>Circulatory</strong> <strong>Health</strong> Magazine
U-Prevent<br />
Smart website<br />
about<br />
customized<br />
medication<br />
internist in training<br />
Jannick Dorresteijn<br />
and Professor<br />
in vascular medicine<br />
Frank Visseren<br />
In the event of cardiovascular disease or a risk of cardiovascular disease, treatment<br />
comprises of not only adopting a healthy lifestyle, but also anticoagulants,<br />
anti-hypertensives and cholesterol-lowering products. Internist and professor in<br />
vascular medicine Frank Visseren and internist in training Jannick Dorresteijn treat<br />
patients in the outpatient clinic. "We know from large-scale studies that they are very<br />
effective and safe medicines," says Jannick. "But the medication is fitted for the<br />
average patient and does not work as effectively for everyone."<br />
Old-fashioned<br />
According to Frank, even though we are living in 2018, we are still practicing very<br />
old-fashioned medicine. "Just imagine," he says. "A large-scale study shows that a<br />
patient group gets 30% less cardiovascular disease when using a certain medicine.<br />
That's an average figure, based on the results of tens of thousands of patients. We<br />
then prescribe this medication for the entire patient population. Because we don't<br />
know in advance who will benefit from it and who won't. We also don't yet recognize<br />
the patients for whom it would be useful to lower blood pressure and cholesterol to<br />
below the target values. And that's a shame, because you'd want to intensify<br />
treatment for this group."<br />
U-Prevent<br />
"We must do better," Frank and Jannick thought about nine years ago. The result is<br />
U-Prevent, a smart website that calculates exactly how much an individual patient<br />
will benefit from medication to prevent cardiovascular diseases.<br />
To create the website, they analyzed data from various large-scale international<br />
research cohorts and trials. Frank: "We use our Utrecht SMART cohort and work<br />
together with researchers in the Netherlands and abroad. We now have access to<br />
data from more than a million patients, for whom all kinds of measurements have<br />
been performed for these studies. We also know how they did over five or ten years'<br />
time. And that's a veritable treasure trove of information."<br />
Calculation models<br />
Together with professor Yolanda van der Graaf of the UMC Utrecht Julius Center,<br />
they made several algorithms of these enormous quantities of individual data, using a<br />
heavy-duty computer. These algorithms constitute arithmetical models that can be<br />
used in practice. Jannick: "We converted these into an attractive and practical<br />
application that healthcare professionals can use as soon as they consider<br />
prescribing preventive medication. They can use it to predict and show the effect of<br />
the medicine for this individual patient: "If you take this medication, you will ><br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 47
postpone a heart attack or stroke by an average of three years. If you combine this<br />
with a second medicine, the expected gain is as much as five years."<br />
Revolution<br />
According to Frank, the availability of this type of big data will trigger a revolution in<br />
medicine. "It enables us to very accurately predict the effect of drugs in individual<br />
patients," he says. "We can even make life-time predictions: this is the effect if you<br />
use this drug until you're 85." According to the two internists, it is becoming<br />
increasingly important to make a better individual assessment when prescribing<br />
medication. Jannick: "For instance, there are new cholesterol-lowering drugs and<br />
anticoagulants that are more effective, but that can also entail more risks and higher<br />
costs. You'd want to prescribe them to the right patients."<br />
<strong>Health</strong>y lifestyle<br />
Can U-Prevent also be used to measure the effect of a healthy lifestyle? "No," says<br />
Frank. “Because a healthy lifestyle is good for everyone. A healthy weight, more<br />
exercise, no smoking. That's the first step. Smoking in particular is a key factor. Only<br />
when everything has been done in terms of a healthy lifestyle will U-Prevent come<br />
into view. Incidentally, there are also people who have a very healthy lifestyle but<br />
nevertheless benefit greatly from drugs that reduce the risk of cardiovascular<br />
disease. We can show this effect. For patients with or without cardiovascular disease,<br />
with or without diabetes, for young and old.<br />
A real difference<br />
Jannick has noticed that many doctors in the outpatient clinic give their patients<br />
comprehensive information about the potential adverse effects of drugs. "But they<br />
never discuss the advantages as comprehensively," he says. "Perhaps because there's<br />
so little they can be certain of." Opting for medication may mean you have to take it<br />
for life and visit a specialist for a check-up occasionally. Jannick: "That's why it's good<br />
that we show patients what the effects of treatment will be. Many people do not<br />
realize that medication increases their chances of staying healthy until they're old.<br />
For everyone all over the world<br />
U-Prevent is expected to be available from July 2018. On the internet, in<br />
different languages and accessible for everyone all over the world. Frank:<br />
"We created the website with support from the Heart Foundation and ZonMW.<br />
We want to generate added social value with it, which matches the philosophy<br />
of science in transition.” The developers have every confidence in the future<br />
of U-prevent. Jannick: "It can be used by family doctors, nurse practitioners,<br />
cardiologists, internists and all kinds of other specialists. And by patients<br />
themselves, if, once they're back home, they want to check in peace and quiet<br />
what exactly the doctor said."<br />
The Netherlands has some 1.4 million patients with<br />
cardiovascular disease.<br />
The strategic theme <strong>Circulatory</strong> <strong>Health</strong> pays a lot of attention to<br />
prevention of cardiovascular diseases and performs research into risk<br />
factors and healthy lifestyle to enable us to prevent the risk of<br />
cardiovascular disease even better.<br />
48 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Imaging of<br />
heart failure<br />
Faster, more detailed and more patient-friendly cardiac<br />
MRI imaging. That is what professor of cardiovascular<br />
radiology Tim Leiner wants to achieve with his study of<br />
new techniques for optimal imaging of heart and blood<br />
vessels. "So that we gain insight into heart failure -<br />
which, unfortunately, is still a poorly understood<br />
disorder - and treat patients better."<br />
When we refer a patient to the cardiologist, they usually<br />
do an ultrasound of the heart. "This already tells us a lot<br />
about the heart and blood vessels," says Tim. "But<br />
sometimes it is not enough to make a diagnosis. The<br />
cardiologist needs a better picture and requests a<br />
cardiac MRI from radiology." To do an MRI of the heart,<br />
the patient is injected with contrast agent and lies on<br />
the MRI table for about an hour, so that the radiologist<br />
can produce all images needed to answer the clinical<br />
questions. Tim: "We may be looking for a disorder of<br />
the heart valves, coronary artery disorder or genetic<br />
disorder. Or diastolic heart failure, which is when the<br />
heart muscle does not relax enough during the resting<br />
phase of the heart. This mainly affects women."<br />
New MRI technology<br />
At UMC Utrecht, we use the latest, state-of-the-art MRI<br />
equipment, says Tim. "Better than this is not possible -<br />
at this time. So what we envisage for our research must<br />
still be built. To this end, we work closely together with<br />
cardiologists - from other UMCs - as well as<br />
technological companies. Together, we want to develop<br />
new MRI technology with which we can make images<br />
of the heart and blood vessels more quickly, in much<br />
less time than one hour. We also want to make more<br />
detailed images, such as images of heart muscle fibers.<br />
That will enable us to detect the early stages of diastolic<br />
heart failure sooner and treat it more effectively. MRI of<br />
the heart plays an increasingly important role in<br />
detecting and determining the severity of heart failure<br />
and, consequently, in treating it."<br />
<strong>Circulatory</strong> <strong>Health</strong> Magazine 49
He has a heart of gold I mean it from the bottom<br />
of my heart Doing something<br />
with heart and soul It breaks my heart<br />
A man after my own heart I have everything<br />
my heart desires Find it in your heart to<br />
forgive Her heart is in the right place Wearing your<br />
heart on your sleeve Stay close to your heart<br />
My heart is not in it Home is where the heart is<br />
She holds a special place in my heart<br />
Losing your heart to someone<br />
Have a heart-to-heart Out of the goodness of my heart<br />
Letting your heart rule your head My heart<br />
skipped a beat Putting your heart at rest<br />
50 <strong>Circulatory</strong> <strong>Health</strong> Magazine
Colophon<br />
Publication 2018<br />
PUBLISHED BY<br />
Strategic theme <strong>Circulatory</strong> <strong>Health</strong>, UMC Utrecht<br />
EXECUTIVE EDITORS<br />
Rick Grobbee, Marco Houterman, Bas Kooman,<br />
Elke Lautenbag, Heleen Romeijn<br />
DESIGN<br />
Barbara Hagoort,<br />
marketing & communication, UMC Utrecht<br />
IMAGE COORDINATION<br />
Jelle Westerhoff,<br />
marketing & communication, UMC Utrecht<br />
TEXT<br />
Sigrid Dekker, Riëtte Duynstee, Karin Fleuren,<br />
Sandra Genet, Lonneke Homfeld, Elke Lautenbag,<br />
Heleen Romeijn, Marjon Waller<br />
PHOTOGRAPHY<br />
UMC Utrecht, marketing & communication:<br />
Erik Kottier, Thirza Luijten, Ivar Pel,<br />
Ed van Rijswijk, Rogier Veldman<br />
ILLUSTRATIONS<br />
Thinkstockphotos.com<br />
PRINTING<br />
De Bondt grafimedia communicatie, Barendrecht<br />
CIRCULATORY HEALTH PROGRAM COMMITTEE<br />
Rick Grobbee, Gert Jan de Borst, Pieter Doevendans,<br />
Tim Leiner, Folkert Asselbergs, Yvonne van der Schouw,<br />
Frank Visseren and Bart van der Worp<br />
CONTACT<br />
Marco Houterman, program manager<br />
Strategic theme <strong>Circulatory</strong> <strong>Health</strong><br />
Room number Str. 5.109, internal mail number Str. 6.131<br />
T +31 88 75 593 84<br />
E hartenvaten@umcutrecht.nl<br />
www.umcutrecht.nl
Support our<br />
research<br />
Cardiovascular diseases represent one of the leading<br />
causes of death in women. We want to detect heart<br />
failure in women earlier and treat it better.<br />
Will you help us?<br />
steunhetvrouwenhart.nl